NDC 0173-0901
Sotrovimab
Sotrovimab
Sotrovimab is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Sotrovimab.
Product ID | 0173-0901_55b0f153-afab-4e61-9e68-6674f99d1ebe |
NDC | 0173-0901 |
Product Type | Human Prescription Drug |
Proprietary Name | Sotrovimab |
Generic Name | Sotrovimab |
Dosage Form | Injection, Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-05-26 |
Marketing Category | UNAPPROVED DRUG OTHER / |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | SOTROVIMAB |
Active Ingredient Strength | 63 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |